Michael studied biochemistry at the University of Glasgow, before completing a PhD at Queen Mary University of London where he investigated how cells communicate. After that he worked in a science press office and joined Cancer Research UK’s News and Multimedia team in 2016, where he writes for the blog and news feed.
Using the PSA test for screening, and a plan to cut calories: check out the stories behind this week’s headlines.
‘Mini tumours’ to help guide treatment and NHS approval for three thyroid cancer drugs were in the news this week.
Vaping as well as cancer survival stats were in the news this week. We take a look behind the headlines in our roundup.
E-cigarettes are in the news again, but the headlines linking them to cancer don’t match the research.
A cancer blood test is in the news today, but it’s too early to say if it will work. We take a look at what questions still need to be answered.
CRISPR genome editing has received lots of attention and hype, so we took a look at what it really means for the future of cancer research.
By combining radiotherapy with different kinds of drugs, scientists hope that both can be made more effective.
Our top stories this week include evidence of delays to cancer diagnosis, as well as the most googled health question of the year.
This week saw diabetes and extra weight linked to cancer, as well as a case of a man whose HIV was brought under control by a lung cancer drug.
This week saw two breast cancer drugs approved in England, and Scotland winning the right to set a minimum price for units of alcohol.